(2026). Frequency and Risk Factors of Red Cell Alloimmunization in Transfused Patients with Sickle Cell Disease and Sickle Cell–β Thalassemia: A Three-Year Retrospective Study from a Tertiary Care Centre. Current Clinical and Medical Education.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Frequency and Risk Factors of Red Cell Alloimmunization in Transfused Patients with Sickle Cell Disease and Sickle Cell–β Thalassemia: A Three-Year Retrospective Study from a Tertiary Care Centre."
Current Clinical and Medical Education 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Frequency and Risk Factors of Red Cell Alloimmunization in Transfused Patients with Sickle Cell Disease and Sickle Cell–β Thalassemia: A Three-Year Retrospective Study from a Tertiary Care Centre."
Current Clinical and Medical Education, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.